04:31 PM EDT, 06/12/2024 (MT Newswires) -- Samuel C. Blackman, Head of R&D, on June 10, 2024, sold 30,000 shares in Day One Biopharmaceuticals ( DAWN ) for $378,588. Following the Form 4 filing with the SEC, Blackman has control over a total of 2,141,081 shares of the company, with 1,141,081 shares held directly and 1,000,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1845337/000141588924016507/xslF345X03/form4-06122024_080612.xml

Price: 12.80, Change: -0.20, Percent Change: -1.54